AT
ABBV icon

Avalon Trust’s AbbVie ABBV Stock Holding History

Avalon Trust’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$923K Sell
3,666
-400
-10% -$86.1K 0.06% 75
2026
Q1 		$884K Buy
4,066
+788
+24% +$175K 0.06% 71
2025
Q4 		$749K Sell
3,278
-178
-5% -$40.5K 0.05% 76
2025
Q3 		$800K Buy
3,456
+184
+6% +$37.5K 0.05% 79
2025
Q2 		$607K Buy
3,272
+560
+21% +$104K 0.04% 84
2025
Q1 		$568K Sell
2,712
-60
-2% -$11.7K 0.05% 91
2024
Q4 		$493K Hold
2,772
– – 0.04% 95
2024
Q3 		$547K Sell
2,772
-923
-25% -$172K 0.04% 85
2024
Q2 		$634K Sell
3,695
-255
-6% -$42.2K 0.05% 79
2024
Q1 		$719K Sell
3,950
-100
-2% -$17.2K 0.06% 79
2023
Q4 		$628K Buy
4,050
+330
+9% +$48.1K 0.06% 76
2023
Q3 		$555K Sell
3,720
-121
-3% -$17.8K 0.05% 77
2023
Q2 		$517K Sell
3,841
-78
-2% -$11.4K 0.05% 82
2023
Q1 		$625K Buy
+3,919
New +$599K 0.06% 76

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Avalon Trust's ABBV Position: Q2 2026 in Review

Avalon Trust reduced its AbbVie (ABBV) stake by 9.8% in Q2 2026, selling an estimated $86.1K and leaving 3,666 shares worth $923K. The position accounts for 0.06% of the portfolio, ranked #75.

Avalon Trust first reported a position in ABBV in Q1 2023 and has held it in 14 quarters since. 4,201 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Avalon Trust held 3,666 shares of AbbVie worth $923K as of Q2 2026.
  • Avalon Trust sold 400 AbbVie shares in Q2 2026, an estimated $86.1K.
  • AbbVie made up 0.06% of Avalon Trust's portfolio in Q2 2026, its #75 holding.
  • Avalon Trust first reported a position in AbbVie in Q1 2023 and has held it in 14 quarters since.
  • 4,201 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Avalon Trust's 13F filing for Q2 2026, filed 6 Aug 2026.